Gastric Bypass Surgery as an Alternative Treatment to Pharmacologic Therapy for Lowering HbA1c in Obese Type 2 Diabetic Patients

Author

Pooja Kachhia, University of the PacificFollow

Date of Award

4-1-2019

Document Type

Capstone

Degree Name

Master of Physician Assistant Studies

Department

Physician Assistant Education

First Advisor

Rahnea Sunseri

Abstract

Focusing on therapy, many options are available for treating T2DM; however, of the numerous treatment choices, determining the most effective disease control is paramount. T2DM therapeutic measures includes lifestyle modifications, such as eating healthfully, exercising regularly, and losing excess weight. In addition, medicines are also prescribed to lower blood sugar to help prevent and delay complications. While the use of prescription medications to treat T2DM is a widely accepted and effective intervention, recent studies have shown that Roux-en-Y gastric bypass procedure can be an alternate and potentially more effective treatment. Although it is primarily used for bariatric therapy, Roux-en-Y gastric bypass surgery is currently being studied as an option to aid in glycemic control in adults with T2DM.

This research paper explores the effectiveness of Roux-en-Y gastric bypass surgery compared to pharmacologic therapy for improving the plasma glucose and glycosylated hemoglobin (HbA1c) levels in obese T2DM patients.

Recommended Citation

Kachhia, Pooja, "Gastric Bypass Surgery as an Alternative Treatment to Pharmacologic Therapy for Lowering HbA1c in Obese Type 2 Diabetic Patients" (2019). Physician Assistant Capstones. 25.
https://scholarlycommons.pacific.edu/pa-capstones/25